Q3 2024 Rapid Micro Biosystems Inc Earnings Call Transcript
Key Points
- Rapid Micro Biosystems Inc (RPID) reported a 24% increase in total revenue for the third quarter, reaching $7.6 million, marking a quarterly revenue record.
- The company placed seven Growth Direct systems across North America, Europe, and Asia Pacific, marking their strongest placement quarter since Q3 2021.
- Gross margins improved significantly, with a 35% point improvement year-over-year, resulting in positive 8% gross margins.
- The company reaffirmed its full-year 2024 revenue outlook of at least $27 million, indicating confidence in continued growth.
- Rapid Micro Biosystems Inc (RPID) is actively engaged with several customers planning to expand their Growth Direct footprint, demonstrating strong business momentum and customer interest.
- The company is still facing elongated purchasing cycles and more scrutiny in the purchasing process, indicating potential market headwinds.
- Operating expenses remained flat compared to Q3 last year, with $0.6 million in one-time severance and other expenses impacting the quarter.
- Net loss for the third quarter was $11.3 million, compared to a net loss of $13.4 million in Q3 last year, indicating ongoing financial challenges.
- The company expects to burn roughly $40 million in cash for the full year 2024, highlighting ongoing cash flow concerns.
- Despite improvements, product margins were near break-even at negative 1%, indicating room for further cost reductions and efficiency improvements.
Thank you for standing by. My name is Novi and I will be your conference operator today. At this time. I would like to welcome everyone to the Rapid Micro Biosystems third quarter, 2024 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question. Press star one again. Thank you. I would now like to turn the call over to Michael Beaulieu with investor relations. Please go ahead.
:,-
Good morning and thank you for joining the Rapid Micro Biosystems third quarter, 2024 earnings call. Joining me on the call are Robert Spignesi, President and Chief Executive Officer and Sean Wirtjes Chief Financial Officer.
Earlier today, we issued a press release announcing our third quarter 2024 financial results. A
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
